跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYFNUA 45 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LYFNUA 45 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
LYFNUA 45 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 19, 2024
Approval ID
fd99a984bf7ce82a
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
fd99a984bf7ce82a
Drug Cima Aemps Name
LYFNUA 45 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1211613002
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Merck Sharp & Dohme De Espana S.A.
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2024-06-19
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
45 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme BV
Country Name
Netherlands
Active Ingredients
GEFAPIXANT
45 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 19, 2024
Approval ID
fd99a984bf7ce82a
Type
Standard
Back to CIMA-AEMPS Approvals
